共 50 条
- [1] ASO Visual Abstract: Mutational Status is Associated with Higher Rate of Pathologic Complete Response After Neoadjuvant Chemotherapy in Hormone Receptor-Positive Breast Cancer Annals of Surgical Oncology, 2023, 30 : 8469 - 8470
- [2] Mutational Status is Associated with a Higher Rate of Pathologic Complete Response After Neoadjuvant Chemotherapy in Hormone Receptor-Positive Breast Cancer Annals of Surgical Oncology, 2023, 30 : 8412 - 8418
- [5] ASO Visual Abstract: Neoadjuvant Endocrine Therapy as an Alternative to Neoadjuvant Chemotherapy Among Hormone Receptor Positive Breast Cancer Patients—Pathologic and Surgical Outcomes Annals of Surgical Oncology, 2021, 28 : 657 - 658
- [7] ASO Visual Abstract: Association of Tumor Molecular Subtype and Stage with Breast and Axillary Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer Annals of Surgical Oncology, 2022, 29 : 3864 - 3864
- [8] ASO Visual Abstract: Relationship Between Breast and Axillary Pathologic Complete Response in Women Receiving Neoadjuvant Chemotherapy for Breast Cancer Annals of Surgical Oncology, 2021, 28 : 633 - 634
- [10] ASO Visual Abstract: Discordant Breast and Axillary Pathologic Response to Neoadjuvant Chemotherapy Annals of Surgical Oncology, 2023, 30 : 8467 - 8468